Hurone AI Secures Strategic Investment from Vetrinox Capital to Accelerate Deployment of EHR-Integrated Oncology Tool
Investment supports Hurone AI’s commercial scale across US academic cancer centers, driving CMS reimbursement
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.
Investment supports Hurone AI’s commercial scale across US academic cancer centers, driving CMS reimbursement automation & proactive patient navigation.
SEATTLE, CA, UNITED STATES, September 15, 2026 /EINPresswire.com/ — Hurone AI, an artificial intelligence company pioneering EHR-integrated oncology navigation infrastructure, today announced a strategic investment from Vetrinox Capital, the family office of Nigerian entrepreneur Osahon Okunbo. The capital will accelerate commercial execution and deployment across top-tier U.S. academic cancer centers.
The company has moved beyond early clinical validation toward enterprise deployment. In its flagship deployment at the UCSF Brain Tumor Center, Hurone AI analyzed over 225,000 patient interactions across 845 patients, demonstrating that 75% of neuro-oncology EHR messages were automatically resolvable without direct clinician intervention.. To drive equitable risk stratification, Hurone AI secured strategic alignment with Mayo Clinic, licensing its HOUSES social determinants of health (SDOH) framework. With an A+ independent cybersecurity rating and native integration into Epic EHR, Hurone AI provides the compliance, security, and technical infrastructure required for immediate enterprise hospital adoption.
Natively integrated into Epic EHR, Hurone AI’s Hurona platform automates complex clinical workflows, reduces provider burnout, and unlocks new high-margin revenue for health systems by automating CMS oncology navigation billing codes.
“Cancer is fought in the hours no one sees, and in the questions no one can bring themselves to ask,” said Osahon Okunbo, Founder and Chairman of Vetrinox Capital. “Kingsley is building the thing that sits with people in those hours. I have wanted something like this to exist for a long time.”
Vetrinox Capital is a Lagos based family office founded and chaired by Osahon Okunbo. The firm’s diversified portfolio spans energy, agriculture, hospitality, and the creative economy across Nigeria and pan African markets, and the Hurone AI investment marks its first commitment to United States healthcare.
Vetrinox Capital is expanding its investment activities into companies developing commercially viable solutions to significant social and economic challenges. The Hurone AI investment reflects that direction.
“This strategic investment from Osahon Okunbo comes at a pivotal moment of scaling and technical acceleration for Hurone AI,” said Dr. Kingsley Ndoh, Founder and CEO of Hurone AI. “As we deploy our flagship platform across top-tier academic research centers and expand our reach across the United States, aligned capital from visionaries who deeply understand our mission is paramount. Fueled by a profound personal commitment to making cancer a survivable condition, Osahon’s backing accelerates our vision to bridge clinical gaps and deliver high-touch, AI-powered oncology care to millions of vulnerable patients nationwide.”
Health equity anchors the mission: ensuring that a patient’s zip code or socioeconomic background never dictates their ability to survive a cancer diagnosis. By deploying across top tier academic research hospitals, Hurone provides the scalable data architecture necessary to bridge care gaps, solve health disparities, and scale precision oncology globally.
About Vetrinox Capital
Vetrinox Capital is a Lagos based family office founded and chaired by Osahon Okunbo, investing across energy, agriculture, hospitality, and the creative economy. The firm’s investment philosophy is shaped by Okunbo’s extensive operating and leadership experience across infrastructure, energy, and hospitality. For more information, visit https://vetrinoxcapital.net.
About Hurone AI
Hurone AI is a highly integrated AI-native navigation infrastructure for oncology, designed to extend the reach of clinicians beyond the four walls of the clinic. Built on a proprietary foundation of diverse clinical data and natively integrated into the Epic EHR, Hurone securely automates complex workflows and social risk stratification to improve patient adherence and outcomes. By deploying at top-tier research hospitals, Hurone provides the scalable data architecture necessary to solve health disparities and improve patient outcomes while reducing the administrative burden on oncology teams. For more information, visit www.hurone.ai.
Media Contact
Lisette Martje Rauwendaal
Hurone AI, Inc
Press@hurone.ai
Lisette Martje Rauwendaal
Hurone AI, Inc
email us here
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Media gallery
